With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...
If you're patient, these businesses have a lot of promising projects in the works. Much to the chagrin of investors ... Merck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback